Verastem (VSTM) EBITDA Margin: 2018-2025
Historic EBITDA Margin for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to -851.92%.
- Verastem's EBITDA Margin fell 293964.00% to -851.92% in Q3 2025 from the same period last year, while for Sep 2025 it was -2,376.94%, marking a year-over-year decrease of 427034.00%. This contributed to the annual value of -1,306.50% for FY2024, which is 341701.00% down from last year.
- According to the latest figures from Q3 2025, Verastem's EBITDA Margin is -851.92%, which was down 107.35% from 11,596.70% recorded in Q2 2025.
- Verastem's 5-year EBITDA Margin high stood at 449,975.00% for Q3 2022, and its period low was -1,139,900.00% during Q3 2021.
- Moreover, its 3-year median value for EBITDA Margin was 2,127.09% (2023), whereas its average is 5,184.44%.
- As far as peak fluctuations go, Verastem's EBITDA Margin plummeted by 113,991,671bps in 2021, and later soared by 158,987,500bps in 2022.
- Quarterly analysis of 5 years shows Verastem's EBITDA Margin stood at -3,022.75% in 2021, then skyrocketed by 533,891bps to 2,316.16% in 2022, then plummeted by 44,820,742bps to 1,767.58% in 2023, then spiked by 32,014bps to 5,632.72% in 2024, then plummeted by 293,964bps to -851.92% in 2025.
- Its last three reported values are -851.92% in Q3 2025, 11,596.70% for Q2 2025, and 23,679.17% during Q1 2025.